Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2025-03-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
五矿证券有限公司关于湖北一致魔芋生物科技股份有限公司2024年度募集资金存放与使用情况的专项核查报告
Regulatory Filings
2025-03-23 Chinese
2024年年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by 湖北一致魔芋生物科技股份有限公司. It includes specifics on the total amount raised, net proceeds, timing of fund receipt, usage of funds, balance of funds, and compliance with regulatory requirements. It also contains auditor and sponsor opinions verifying the proper use and storage of the raised funds. The document references regulatory approvals and compliance with stock exchange rules, and it is titled as a "专项报告" (special report) on the storage and use of raised funds. This type of document corresponds to a Capital/Financing Update (CAP), as it provides updates on fundraising activities and the management of capital raised, rather than being a full annual or interim financial report or an announcement of a report publication. The document length is over 5,000 characters and contains substantive financial data related to capital raising and usage, confirming it is not merely an announcement or certification. Therefore, the appropriate classification is CAP.
2025-03-23 Chinese
内部控制审计报告
Regulatory Filings
2025-03-23 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled as an "年度报告" which translates to "Annual Report". It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and financial accounting reports. The document includes audited financial data for the fiscal year 2024, with specific financial metrics, quarterly data, and notes on accounting policies and changes. It also references an audit report with an unqualified opinion from an accounting firm. The length of the document (15,000 characters) and the depth of financial and operational information confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-03-23 Chinese
湖北一致魔芋生物科技股份有限公司年度募集资金存放与使用情况鉴证报告
Regulatory Filings
2025-03-23 Chinese
董事会关于独立董事独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements from the China Securities Regulatory Commission and details the board's evaluation of the independence of specific directors. The content is focused on governance and compliance with independence criteria rather than financial results or other report types. The document length is short (922 characters) and it is a standalone report on a specific governance matter. This fits best under Board/Management Information (MANG) as it concerns board-level disclosures about director independence.
2025-03-23 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.